ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CAT CAT Strategic Metals Corporation

0.005
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
CAT Strategic Metals Corporation CSE:CAT CSE Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.005 0.005 0.01 0.005 0.005 0.005 50,000 01:00:00

EMM Disclosure

17/04/2003 11:16am

UK Regulatory


RNS Number:1556K
GoldmanSachs International
17 April 2003


EMM DISCLOSURE

                                                             FORM 38.5 (SUMMARY)


CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS


Name of EMM

Goldman Sachs International


Date of disclosure

17 April 2003


Contact name

Peter Highton




Telephone number

+44 207-774-1935



Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:



Cambridge Antibody Technology Group plc



AMENDMENT

If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:




In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.



For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.

Email: monitoring@disclosure.org.uk


                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:

DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS


Dealing in (name of company)

Cambridge Antibody Technology Group plc




Class of security

Ordinary Shares




Date of disclosure

17 April 2003



Date of dealing

16 April 2003



Name of EMM

Goldman Sachs International




Name of offeree/offeror with whom connected

Oxford Glycosciences plc



Total number of securities purchased

10,063



Highest price paid*

3.40 # Sterling



Lowest price paid*

3.40 # Sterling



Total number of securities sold

10,000



Highest price received*

3.4212 # Sterling



Lowest price received*
3.4212 # Sterling



*Currency must be stated

                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMSFLFSWSDSEFL_SN_RNS1556K_SU_RNSTEST_XX_101623.1786_RZ__RT_R.xRoute.000
~


1 Year CAT Strategic Metals Chart

1 Year CAT Strategic Metals Chart

1 Month CAT Strategic Metals Chart

1 Month CAT Strategic Metals Chart

Your Recent History

Delayed Upgrade Clock